![BeardBros_BlogImages [Recovered]](data:image/svg+xml;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMjU2MCAyOTIiIHdpZHRoPSIyNTYwIiBoZWlnaHQ9IjI5MiIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj48L3N2Zz4=)
Key Takeaways
- The Trump administration faces opposition from Republican senators while pushing for a delay in the federal hemp ban, set to take effect on November 12, 2026.
- The 2018 Farm Bill legalized hemp products, but new stipulations set a low THC threshold, endangering the legality of many products.
- The White House seeks to delay the ban to allow for further discussions on regulatory frameworks, emphasizing the need for a scientific approach to hemp products.
- Conflict of interest questions arise as a report links advocacy efforts for the delay to the personal connections of Trump’s chief of staff.
- Republican senators, including Ted Budd, push against the delay, framing the ban as necessary for public health and safety concerns.
The federal hemp ban debate has been simmering for months. Now it has exploded into one of the more contentious internal Republican fights of the summer. With a November 12 deadline looming, the Trump administration is pushing Congress to include a delay in a stopgap government funding bill, calling it a short window to work out a longer-term regulatory framework.
Several Republican senators are pushing back hard, and according to reports this has added a politically sensitive layer to an already complicated fight.
How Did the Federal Hemp Ban Come About in the First Place?
Hemp-derived products with less than 0.3 percent delta-9 THC on a dry-weight basis became federally legal under the 2018 Farm Bill, which Trump signed during his first term. That opened the door to a booming market in hemp-derived CBD, delta-8, and other cannabinoid products sold across the country in retail stores, gas stations, and online.
Then, in November 2025, Trump signed a new spending package that redefined hemp in ways that will make a sweeping change to that legal landscape. Under the new law, only products containing 0.4 milligrams or less of total THC per container will remain legal after November 12, 2026.
Products exceeding that threshold will effectively become Schedule 1 controlled substances. Industry advocates warn the threshold is so low it would pull full-spectrum CBD products off shelves alongside more potent intoxicating products.
Trump himself acknowledged the problem in an April 2026 Truth Social post. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” he wrote, calling on Congress to fix the law before it took effect.
What Is the White House Asking Congress to Do Right Now?
The Senate Appropriations Committee, in a continuing resolution released Sunday, August 2, included a provision that would delay the hemp ban’s effective date from November 12 to December 11, 2026. That is roughly a four-week extension tied to the expiration date of the short-term funding bill.
The delay is not blanket. Synthetic cannabinoids that cannot be naturally produced by a Cannabis sativa L. plant would still face recriminalization on November 12, as originally scheduled. For everything else, the White House says the extra time is needed.
“The White House supports the provision in the temporary government funding bill, which is a modest four-week delay in implementation to allow for productive conversations to continue,” a White House official told Marijuana Moment.
The administration has been working toward what it describes as a “Gold Science Standard-based framework” to expand hemp-derived treatment options for veterans and patients. White House Budget Director Russell Vought wrote to House Speaker Mike Johnson in June asking Congress to “ensure the fair treatment of hemp products.” The Centers for Medicare and Medicaid Services also launched a program in April 2026 covering up to $500 worth of hemp-derived products annually for eligible Medicare patients.
What Did the New York Times Report Claim?
The story at the center of the political controversy was published by the New York Times earlier this week. According to the Times, the White House pressure campaign to keep hemp THC products legal was “led in part” by Bret Worley, president and CEO of Colorado-based MC Nutraceuticals, a hemp products company.
The reason that matters politically: Worley married Susie Wiles’s daughter Caroline in June 2026 at the Trump Winery in Charlottesville. Wiles is Trump’s chief of staff, arguably the most powerful staffer in the West Wing.
The Times report raised questions about whether the administration’s advocacy on the hemp ban delay was driven by policy goals or by interests that benefit people with close ties to the inner circle of the White House.
How Is the White House Responding to the Conflict of Interest Questions?
The administration has pushed back firmly. Kush Desai, a White House spokesperson, told the New York Times that Worley “had nothing to do” with the president’s stance on the issue. Desai told NBC News that “the only interest guiding the Trump administration’s decision-making is the best interest of the American people.”
Desai also addressed Wiles directly, stating that when she met with lawmakers the previous week to advocate for the continuing resolution, she did not specifically mention the hemp ban and “has never lobbied in favor of this or any other position on hemp with Capitol Hill,” according to the Times report.
The White House framing has been consistent: the push to delay is about protecting veterans and patients who rely on hemp-derived products for medicinal purposes, not about shielding commercial interests.
Worley himself did not comment to the Times.
Which Republican Senators Are Opposing the Delay?
Not everyone in the Senate Republican caucus is on board with the White House position. Sen. Ted Budd of North Carolina filed an amendment to strip the hemp delay provision out of the continuing resolution entirely, arguing the ban should proceed as planned.
Budd told the Times he has “made it clear to the White House and my colleagues in the Senate that any action to delay” the ban “will endanger both the wellness and safety of Americans.”
The dispute came to a head during a closed-door Senate Republican lunch on August 5. According to reports from Punchbowl News and NBC News, White House Director of Legislative Affairs James Braid got into a tense exchange with several senators over the hemp issue, becoming especially contentious with Sen. Tom Cotton of Arkansas.
Senators Cotton, Pete Ricketts of Nebraska, and Budd all argued for letting the ban proceed in November. Cotton reportedly described hemp-derived THC products as “gas-station marijuana candy,” citing concerns about children’s access to the products.
Braid committed at the meeting that there would be no further extensions beyond the one included in the current funding bill.
By August 5, Budd’s amendment had gathered nine Republican cosponsors. Meanwhile, a bipartisan coalition of 35 state and territory attorneys general sent a letter to Congress on August 4 calling on lawmakers not to reverse the ban, saying the forthcoming prohibition “protected consumers, provided much-needed regulatory clarity, and preserved legitimate industrial, agricultural, and nonintoxicating hemp markets.”
Did Trump Personally Call Senator Budd?
Multiple sources say that Trump personally called Budd in an attempt to walk him back from the amendment push. According to Axios and Politico, the call happened Tuesday night, August 4, before Budd spoke to reporters on Wednesday. The call was described as wide-ranging.
On the call, Trump laid out the White House argument for the delay, explaining the administration is working on a broader regulatory framework for hemp THC products and is concerned the November ban could disrupt those plans, according to a source familiar with the discussion.
A spokesperson for Budd clarified afterward that there was “not an explicit ask made to Sen. Budd to drop the amendment” and described the conversation as “very friendly,” noting the hemp issue was one of several topics discussed.
Sen. Rand Paul of Kentucky, a hemp-producing state, spoke in favor of the delay during the GOP lunch. He dismissed the opposition as disproportionate. “They’re wanting to hold up the funding for the government over one month,” Paul said. “It’s kind of insane.”
Sen. Rick Scott of Florida said the White House had committed to him that it would regulate the industry, and indicated that pledge had moved his position.
Where Does the Congressional Path Forward Stand?
The current situation is complicated. The Senate continuing resolution includes the delay provision. However, the House passed its own version of a short-term funding bill in June without any hemp-related provisions. For the Senate version to become law, the House would need to accept the hemp language or negotiate a compromise.
Beyond the continuing resolution fight, several longer-term legislative proposals are circulating in both chambers. Rep. James Comer of Kentucky is circulating a bill that would delay the ban while adding packaging requirements, testing rules, and age restrictions. Rep. Andy Barr of Kentucky filed a bipartisan bill alongside Rep. Angie Craig of Minnesota that would prevent recriminalization while adding taxes and regulations, including a minimum purchase age of 21. The White House has not specifically endorsed either proposal, though it has expressed general support for a regulatory approach.
None of these standalone bills have advanced through congressional leadership to date.
Frequently Asked Questions
The ban is currently scheduled to take effect on November 12, 2026. Under legislation Trump signed in November 2025, hemp products with more than 0.4 milligrams of total THC per container will be reclassified as Schedule 1 controlled substances on that date.
The Senate Appropriations Committee included a provision in its continuing resolution that would push the hemp ban’s effective date back to December 11, 2026, extending it by roughly four weeks. Synthetic cannabinoids that cannot be produced naturally by a cannabis plant would still face the November 12 prohibition.
The White House says it is working on a broader regulatory framework for hemp-derived products, particularly for veterans and patients who use them medicinally. Administration officials say a short delay would allow those conversations to continue without disrupting the broader funding legislation.
Yes. White House spokesperson Kush Desai told the New York Times that Worley “had nothing to do” with the president’s position on hemp and stated that Wiles “has never lobbied in favor of this or any other position on hemp with Capitol Hill.” The administration says its advocacy reflects the interests of American patients, veterans, and farmers.
